Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
3 GLP-1 Stocks to Buy Now For Big Long-Term Gains
09:12am, Sunday, 01'st Sep 2024
The surge in interest investors have displayed for companies delivering weight loss drugs has been impressive.
3 No-Brainer Stocks to Buy in September
07:30am, Saturday, 31'st Aug 2024
Eli Lilly is a growth machine that never runs out of opportunities. Novo Nordisk is still gaining momentum.
These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now
07:10am, Saturday, 31'st Aug 2024
Eli Lilly and Novo Nordisk compete in a handful of different markets. Novo Nordisk is scaling up its output and upgrading its medicines a bit more slowly.
This New Finding About Ozempic and Wegovy Could Hurt Novo Nordisk's Stock
06:15am, Friday, 30'th Aug 2024
Wegovy and Ozempic are based on the same molecule called semaglutide. An investigation into the side effects of semaglutide was just published.
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
04:39am, Friday, 30'th Aug 2024
Bagsværd, Denmark, 30 August 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated pe
Catalent beats revenue estimates ahead of deal close with Novo Nordisk parent
08:07am, Thursday, 29'th Aug 2024
Contract drug manufacturer Catalent beat analysts' estimates for fourth-quarter revenue on Thursday, helped by its biologics segment that develops and manufactures cell and gene therapies.
Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know
10:05am, Wednesday, 28'th Aug 2024
Recently, Zacks.com users have been paying close attention to Novo Nordisk (NVO). This makes it worthwhile to examine what the stock has in store.
We've had "diabesity"; now here's what "pre-diabesity" means for Novo Nordisk, Eli Lily et al
09:12am, Wednesday, 28'th Aug 2024
The surge in GLP-1 obesity-related research is highlighting a critical shift in medical literature, according to a recent analysis by Deutsche Bank. It notes that managing obesity is becoming increasi
Ozempic Could Have a Terrible Side Effect. Is Novo Nordisk in Trouble?
06:00am, Tuesday, 27'th Aug 2024
A recent study claims that Ozempic is linked with a higher risk of suicidal thoughts than other drugs. However, other studies have reached the opposite conclusion.
Novo Nordisk A/S - share repurchase programme
09:44am, Monday, 26'th Aug 2024
Bagsværd, Denmark, 26 August 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Counc
2 No-Brainer Healthcare Stocks to Buy With $1,000
09:30am, Saturday, 24'th Aug 2024
Novo Nordisk's innovative wheel is still spinning and bearing fruit in the form of strong financial results. HCA Healthcare is a leading hospital chain that continues to wrestle market share away from
These Were the Top-Selling GLP-1 Drugs Last Quarter From Eli Lilly and Novo Nordisk
08:00am, Friday, 23'rd Aug 2024
Eli Lilly and Novo Nordisk's top diabetes drugs each brought in more than $3 billion in sales last quarter. Ozempic has been on the market for longer, but its growth rate isn't as impressive as that o
Novo Nordisk Vs. Eli Lilly: Beyond The Weight-Loss Drug Battle
08:51am, Wednesday, 21'st Aug 2024
The rivalry between Novo Nordisk A/S NVO and Eli Lilly and Co LLY has heated up as both companies vie for dominance in the booming obesity-drug market. But for investors, the real story may lie beyond
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
03:35pm, Tuesday, 20'th Aug 2024
Bagsværd, Denmark, 20 August 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated pe
Ozempic and Wegovy use among patients with depression needs more scrutiny, researchers say
11:01am, Tuesday, 20'th Aug 2024
There's a new twist in the ongoing debate over whether drugs widely used for weight loss are linked with thoughts of self-injury or suicide.
